相似文献
1
Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil.
J Clin Microbiol. 2000 Aug;38(8):3119-22. doi: 10.1128/JCM.38.8.3119-3122.2000.
2
Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai.
Diagn Microbiol Infect Dis. 2002 Nov;44(3):245-52. doi: 10.1016/s0732-8893(02)00457-1.
3
Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.
J Clin Microbiol. 2001 Jan;39(1):107-10. doi: 10.1128/JCM.39.1.107-110.2001.
4
Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East.
Diagn Microbiol Infect Dis. 2000 Dec;38(4):227-32. doi: 10.1016/s0732-8893(00)00200-5.
5
Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India.
J Clin Microbiol. 2001 Aug;39(8):2987-90. doi: 10.1128/JCM.39.8.2987-2990.2001.
6
Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.
J Clin Microbiol. 2014 Jun;52(6):2157-62. doi: 10.1128/JCM.00691-14. Epub 2014 Apr 16.
7
Rifampicin resistance in tuberculosis outbreak, London, England.
Emerg Infect Dis. 2005 Jun;11(6):931-4. doi: 10.3201/eid1106.041262.
8
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
J Antibiot (Tokyo). 2014 Apr;67(4):291-7. doi: 10.1038/ja.2013.133. Epub 2013 Dec 11.
9
10
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
BMC Microbiol. 2018 Mar 22;18(1):22. doi: 10.1186/s12866-018-1168-x.
引用本文的文献
1
Multi-drug resistant gene mutation analysis in by molecular techniques.
Iran J Microbiol. 2024 Aug;16(4):459-469. doi: 10.18502/ijm.v16i4.16304.
2
Combined Locked Nucleic Acid Probes and High-Resolution Melting Curve Analysis for Detection of Rifampicin-Resistant Tuberculosis in Northern Thailand.
Diagnostics (Basel). 2022 Sep 24;12(10):2307. doi: 10.3390/diagnostics12102307.
3
Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Clinical Isolates Collected in Guangzhou Chest Hospital, China.
Infect Drug Resist. 2022 Sep 27;15:5655-5666. doi: 10.2147/IDR.S375869. eCollection 2022.
4
Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Isolates in China.
Antibiotics (Basel). 2021 Nov 8;10(11):1367. doi: 10.3390/antibiotics10111367.
5
Mutations Associated with Rifampicin Resistance in Isolates from Moroccan Patients: Systematic Review.
Interdiscip Perspect Infect Dis. 2020 Oct 9;2020:5185896. doi: 10.1155/2020/5185896. eCollection 2020.
6
Characterization of mutations in the rpoB gene conferring rifampicin resistance in Mycobacterium tuberculosis complex isolated from lymph nodes of slaughtered cattle from South Africa.
Braz J Microbiol. 2020 Dec;51(4):1919-1927. doi: 10.1007/s42770-020-00356-4. Epub 2020 Aug 5.
7
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil.
ERJ Open Res. 2019 Aug 5;5(3). doi: 10.1183/23120541.00043-2019. eCollection 2019 Jul.
8
Investigation of the Mutations Causing Rifampin Resistance by Rapid Screening in in North-East of Iran.
Iran J Pathol. 2018 Fall;13(4):429-437. Epub 2018 Sep 25.
9
Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01093-18. Print 2018 Oct.
10
Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis.
Am J Trop Med Hyg. 2016 Dec 7;95(6):1257-1264. doi: 10.4269/ajtmh.16-0120. Epub 2016 Oct 24.
本文引用的文献
1
Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.
Emerg Infect Dis. 1998 Apr-Jun;4(2):195-209. doi: 10.3201/eid0402.980207.
2
The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis--a molecular story.
J Med Microbiol. 1998 Mar;47(3):189-96. doi: 10.1099/00222615-47-3-189.
3
Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece.
J Clin Microbiol. 1998 Jan;36(1):20-3. doi: 10.1128/JCM.36.1.20-23.1998.
4
Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system.
J Clin Microbiol. 1997 Nov;35(11):2802-6. doi: 10.1128/jcm.35.11.2802-2806.1997.
5
Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis.
Am J Respir Crit Care Med. 1997 Jun;155(6):2057-63. doi: 10.1164/ajrccm.155.6.9196115.
6
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.
J Clin Microbiol. 1997 Mar;35(3):719-23. doi: 10.1128/jcm.35.3.719-723.1997.
7
Antimicrobial agent resistance in mycobacteria: molecular genetic insights.
Clin Microbiol Rev. 1995 Oct;8(4):496-514. doi: 10.1128/CMR.8.4.496.
8
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family.
JAMA. 1996 Feb 14;275(6):452-7.
9
Molecular basis of rifampin resistance in Mycobacterium leprae.
Antimicrob Agents Chemother. 1993 Mar;37(3):414-8. doi: 10.1128/AAC.37.3.414.
10
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.
J Clin Microbiol. 1993 Feb;31(2):406-9. doi: 10.1128/jcm.31.2.406-409.1993.
Zotero 插件